Ruikang Biotech-B (02179.HK) nominates Wei Qifang and Wang Jing as executive directors of the company.

Financial APP News Update: Reckon Bio-B (02179.HK) announced that the board of directors received resignation reports from Mr. Li Bu, Ms. Chen Qingqing, and Dr. Hong Kunxue on December 1, 2025. Mr. Li Bu resigned from his positions as executive director, member of the board's remuneration and assessment committee, and authorized representative of the company under Rule 3.05 of the Listing Rules of the Hong Kong Stock Exchange for personal reasons and to dedicate more time to other work. Ms. Chen Qingqing resigned from her positions as executive director, member of the board's nomination committee, and joint company secretary for personal reasons and to devote more time to other work. Dr. Hong Kunxue resigned from his position as executive director for personal reasons and to dedicate more time to other work. Their resignations will take effect from the date of delivery to the board of directors.